Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D V Patel

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
Cellular Signalling|July 10, 1999
Potent inhibitory ligands of the GRB2 SH2 domain from recombinant peptide librariesC P Hart, J E Martin, M A Reed, et al.
Journal of Medicinal Chemistry|October 27, 1995
alpha-Hydroxy phosphinyl-based inhibitors of human reninD V Patel, K Rielly-Gauvin, D E Ryono, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
The asymmetric synthesis and in vitro characterization of succinyl mercaptoalcohol and mercaptoketone inhibitors of matrix metalloproteinasesJ I Levin, J F DiJoseph, L M Killar, et al.
Journal of Medicinal Chemistry|February 3, 1995
Phosphinyl acid-based bisubstrate analog inhibitors of Ras farnesyl protein transferaseD V Patel, E M Gordon, R J Schmidt, et al.
Antimicrobial Agents and Chemotherapy|December 25, 2003
Peptide deformylase inhibitors as antibacterial agents: identification of VRC3375, a proline-3-alkylsuccinyl hydroxamate derivative, by using an integrated combinatorial and medicinal chemistry approachD Chen, C Hackbarth, Z J Ni, et al.
Biochemistry|February 24, 2000
Actinonin, a naturally occurring antibacterial agent, is a potent deformylase inhibitorD Z Chen, D V Patel, C J Hackbarth, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Malonyl alpha-mercaptoketones and alpha-mercaptoalcohols, a new class of matrix metalloproteinase inhibitorsD A Campbell, X Y Xiao, D Harris, et al.
Radiology|May 1, 1996
Resolution of intracranial calcifications in infants with treated congenital toxoplasmosisD V Patel, E M Holfels, N P Vogel, et al.
Journal of Medicinal Chemistry|January 5, 1996
Development of highly potent inhibitors of Ras farnesyltransferase possessing cellular and in vivo activityK Leftheris, T Kline, G D Vite, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Cellular Signalling|July 10, 1999
Potent inhibitory ligands of the GRB2 SH2 domain from recombinant peptide librariesC P Hart, J E Martin, M A Reed, et al.
Journal of Medicinal Chemistry|October 27, 1995
alpha-Hydroxy phosphinyl-based inhibitors of human reninD V Patel, K Rielly-Gauvin, D E Ryono, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
The asymmetric synthesis and in vitro characterization of succinyl mercaptoalcohol and mercaptoketone inhibitors of matrix metalloproteinasesJ I Levin, J F DiJoseph, L M Killar, et al.
Journal of Medicinal Chemistry|February 3, 1995
Phosphinyl acid-based bisubstrate analog inhibitors of Ras farnesyl protein transferaseD V Patel, E M Gordon, R J Schmidt, et al.
Antimicrobial Agents and Chemotherapy|December 25, 2003
Peptide deformylase inhibitors as antibacterial agents: identification of VRC3375, a proline-3-alkylsuccinyl hydroxamate derivative, by using an integrated combinatorial and medicinal chemistry approachD Chen, C Hackbarth, Z J Ni, et al.
Biochemistry|February 24, 2000
Actinonin, a naturally occurring antibacterial agent, is a potent deformylase inhibitorD Z Chen, D V Patel, C J Hackbarth, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Malonyl alpha-mercaptoketones and alpha-mercaptoalcohols, a new class of matrix metalloproteinase inhibitorsD A Campbell, X Y Xiao, D Harris, et al.
Radiology|May 1, 1996
Resolution of intracranial calcifications in infants with treated congenital toxoplasmosisD V Patel, E M Holfels, N P Vogel, et al.
Journal of Medicinal Chemistry|January 5, 1996
Development of highly potent inhibitors of Ras farnesyltransferase possessing cellular and in vivo activityK Leftheris, T Kline, G D Vite, et al.
Pageof 7